SCHEMBL6814481

SCHEMBL6814481

CC(Cc1ccc(OCc2ccc(C(=O)O)o2)cc1)c1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 13/20 0.73
RAB9A P51151 12/20 0.73
POLB P06746 4/20 0.70
KDM4E B2RXH2 1/20 0.70
SMN1; SMN2 Q16637 3/20 0.64
L3MBTL1 Q9Y468 3/20 0.64
KMT2A Q03164 3/20 0.64
MAPK1 P28482 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
HSD17B10 Q99714 1/20 0.60
HSP90AA1 P07900 2/20 0.57
ALDH1A1 P00352 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6814478 0.96 NPC1 (0.76) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL6814492 0.84 NPC1 (0.75) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL6815353 0.83 NPC1 (0.71) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL6815339 0.82 POLB (0.77) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL6814497 0.81 POLB (0.75) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL6810773 0.80 POLB (0.73) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL6815374 0.80 POLB (0.73) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL1756442 0.80 POLB (0.73) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL6810769 0.79 POLB (0.81) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL6814360 0.77 NPC1 (0.76) NPC1RAB9APOLBKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004012656-A2 THIOPHENE AND FURAN DERIVATIVES AS PROSTAGLANDIN AGONISTS AND USE THEREOF APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2004-02-12 WO disclosed